Viewing StudyNCT06491355

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-07-17 @ 11:41 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06491355
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-09
First Post: 2024-06-25
Brief Title: First-Line Treatment Induced With mFOLFOX6 and HLX04 Regimen Following Combined With Serplulimab in MSS Initially Unresectable Metastatic Colorectal Cancer
Sponsor: Sir Run Run Shaw Hospital
Organization: Sir Run Run Shaw Hospital
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Efficacy Self
Safety Issues
Colo-rectal Cancer
Keywords: